Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) FCF Margin (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of FCF Margin readings, the most recent being 130.27% for Q1 2026.

  • On a quarterly basis, FCF Margin rose 42436.0% to 130.27% in Q1 2026 year-over-year; TTM through Feb 2026 was 216.87%, a 11227.0% decrease, with the full-year FY2025 number at 108.78%, up 8387.0% from a year prior.
  • FCF Margin reached 130.27% in Q1 2026 per CBIH's latest filing, down from 10.31% in the prior quarter.
  • The five-year high for FCF Margin was 10.31% in Q4 2025, with the low at 554.63% in Q1 2025.
  • A 4-year average of 242.49% and a median of 229.94% in 2024 define the central range for FCF Margin.
  • Year-over-year, FCF Margin plummeted -52970bps in 2025 and then skyrocketed 42436bps in 2026.
  • Year by year, FCF Margin stood at 347.07% in 2023, then skyrocketed by 72bps to 97.09% in 2024, then soared by 89bps to 10.31% in 2025, then crashed by -1163bps to 130.27% in 2026.
  • Per Business Quant, the three most recent readings for CBIH's FCF Margin are 130.27% (Q1 2026), 10.31% (Q4 2025), and 428.56% (Q3 2025).